EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
NCT02117375 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115
Last updated 2020-06-11
Summary
The purpose of this study is to evaluate the prognostic value of early focal lesions and early diffuse lesions on ambulatory disability progression within 5 years after clinical onset.
Conditions
Interventions
- DEVICE
-
spinal cord MRI follow-up
Evaluation : focal lesions (number, volume, localisation), atrophy, parameters from Diffusion Tensor Imaging and parameters from Magnetization Transfer Ratio
- OTHER
-
clinical follow-up
Relapses, treatments, global disability,walking performance, upper limbs motor performance, sphincter disturbances and walking difficulty
- OTHER
-
brain MRI follow-up
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Gilles GE Edan · CHU Rennes
-
Bruno BB Brochet · University Hospital, Bordeaux
-
Thibault TM Moreau · CHU Dijon
-
Sandra SV Vukusic · Hospices civils Lyon
-
Jean JP Pelletier · AP-HM
-
Marc MD Debouverie · CHU NANCY
-
Bruno BS Stankoff · Pitié Salpêtrière
-
Ayman AT Tourbah · CHU REIMS
-
Jérôme JD De Seze · CHU Strasbourg
-
David DB Brassat · University Hospital, Toulouse
-
Pierre PL Labauge · University Hospital, Montpellier
-
Thibaut TM Moreau · University Hospital, Clermont-Ferrand
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2022-04-30
- Completion
- 2022-07-31
Countries
- France
Study Locations
More Related Trials
-
Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters
NCT03108573 ·Status: COMPLETED
-
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
NCT03356366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study
NCT03624296 ·Status: UNKNOWN ·Phase: NA
-
Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
NCT01723631 ·Status: TERMINATED ·Phase: NA
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
NCT07135752 ·Status: RECRUITING ·Phase: NA
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
NCT07292480 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
NCT05941975 ·Status: RECRUITING ·Phase: NA
-
Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients
NCT02290587 ·Status: COMPLETED ·Phase: NA
-
OFSEP Very High Definition Cohort
NCT05622643 ·Status: RECRUITING
-
Metacognition Assessment in Patient With Multiple Sclerosis
NCT04240379 ·Status: COMPLETED
-
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
NCT03632473 ·Status: COMPLETED
-
Multiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI Characteristics
NCT03854123 ·Status: COMPLETED
-
Cognition Evolution and MRI Markers in PPMS Patients on 2 Years
NCT03455582 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
NCT01392872 ·Status: COMPLETED ·Phase: NA
-
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
NCT07189325 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy
NCT00861172 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
NCT06592703 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
NCT00241254 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Empathy in MS
NCT05332951 ·Status: COMPLETED